Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hordenine is a naturally occurring phenethylamine alkaloid found in various plants, especially barley (Hordeum species). Structurally, it is the N,N-dimethyl derivative of tyramine, and is biosynthesized by stepwise N-methylation of tyramine. Hordenine is used as an ingredient in some dietary supplements, often promoted as a CNS stimulant or nootropic and for purported fat-burning or weight-loss effects, though these uses lack robust clinical support. Mechanistically, hordenine acts as an indirectly acting adrenergic compound, liberating norepinephrine from stores, and has been shown to function as a monoamine oxidase B (MAO-B) inhibitor. Animal studies indicate it increases blood pressure and heart rate at high parenteral doses, though these effects are largely absent with oral administration. Hordenine also inhibits the uptake of various bioamines and has minor antibacterial and antibiotic properties. Human data are limited, and most research is preclinical. It is included in some athletic supplements and pre-workouts, but safety and efficacy in humans are not well established[1][2][3][5][7][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hordenine.